Literature DB >> 6164764

Measles antibodies, kappa-lambda light chain distribution and immunoglobulins in serum, cerebrospinal fluid and brain of a patient affected with multiple sclerosis.

F Bollengier, A Mahler, G Clinet.   

Abstract

The serum, cerebrospinal (CSF) and brain of a patient (NAG) affected with multiple sclerosis (MS) were examined for measles antibodies with CF and HI techniques, and the kappa-lambda light chain ratios of all samples available were evaluated, kappa-lambda populations of the matched serum, CSF and brain specimens were all lambda-predominant and in agreement with each other; the light chain distribution f the brain specimens confirmed previous findings [3]. Only the serum immunoglobulins showed significant measles antibody titers, but slightly increased measles antibody titers were also observed in ventricular plaques. The amount of immunoglobulin G (IgG) synthesized per day by the central nervous system (CNS) was estimated. The IgG synthesis in CNS NAG (11.6 mg/day) was above the upper limit of the normal range (3.3 mg/day), but apparently there was no positive correlation between the intracerebral IgG synthesis and specific anti-measles IgG.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164764     DOI: 10.1007/BF00313326

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

2.  A longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis. A preliminary report.

Authors:  M Reunanen; P Arstila; H Hakkarainen; J Nikoskelainen; A Salmi; M Panelius
Journal:  Acta Neurol Scand       Date:  1976-10       Impact factor: 3.209

3.  Multiple sclerosis: local synthesis of electrophoretically restricted measles, rubella, mumps and herpes simplex virus antibodies in the central nervous system.

Authors:  H J Nordal; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

Review 4.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

5.  Letter: Viral-antibody detection by a more sensitive complement-fixation reaction.

Authors:  G Zissis; G Clinet
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

6.  Acute multiple sclerosis: electron-microscopic evidence for and against a viral agent in the plaques.

Authors:  M Dubois-Dalcq; G Schumacher; J L Sever
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

Review 7.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

Review 8.  Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects.

Authors:  E J Thompson
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

9.  Immunoglobulin-containing cells in multiple-sclerosis plaques.

Authors:  M M Esiri
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

10.  Intracerebral synthesis of antibodies to measles and distemper viruses in patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  N T Gorman; J Habicht; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.